Extracellular Vesicle-Derived Bioactive Molecules for Corneal and Ocular Surface Regeneration

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Cell Biology

Background:

• Cell-based therapies are gaining traction for treating diseases.
• Extracellular vesicles (EVs) offer a promising cell-free therapeutic alternative.
• Ophthalmology is exploring EVs for ocular surface diseases like corneal disorders and dry eye.

Purpose of the Study:

• To review recent studies on bioactive molecules within EVs.
• To investigate how these molecules influence cellular activity on the ocular surface.
• To identify key therapeutic agents within EVs for ophthalmic applications.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of EV cargo composition, including transcription factors, growth factors, and nucleic acids.
• Focus on studies investigating molecular activity in recipient ocular cells.

Main Results:

• EVs contain diverse functional molecules like mRNA, miRNA, and growth factors.
• MicroRNAs (miRNAs) are frequently identified as key therapeutic agents.
• Mesenchymal stem cell-derived EVs are commonly studied for ophthalmic applications.

Conclusions:

• EVs hold significant therapeutic potential for ocular surface diseases.
• Understanding the specific activity of EV cargo is crucial for therapeutic development.
• miRNAs within EVs are promising candidates for modulating ocular surface cell activity.